Abstract
In this issue of Cancer Discovery , Adams and colleagues present the discovery of a potent PROTAC, MDM2 degrader, which activates wild-type p53 leadin......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
